Celularity Inc (CELU)
Healthcare
Biotechnology
0.66 $
+3.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Celularity Inc (CELU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -5.1 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11 | -8.3 | -8.3 | -4.4 | -4.3 | -0.1 | 1.6 | 1.6 | -1.0 | -4.2 | -5.1 | -5.1 | -15 | |
| 4.5 | 2.3 | 2.3 | 2.2 | 2.3 | 1.9 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 1.8 | 7.3 | |
| 3.9 | 3.6 | 3.6 | 3.0 | 3.6 | 2.7 | 3.1 | 3.1 | 2.4 | 2.0 | 3.3 | 3.3 | 11 | |
| 28 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.2 | 1.8 | 0.2 | -2.1 | -33 | 8.7 | 9.7 | 9.7 | 15 | 6.7 | 7.9 | 7.9 | 37 | |
| 0.0 | 0.2 | 0.2 | 0.0 | 0.6 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | |
| 0.0 | – | -0.2 | – | -0.6 | 0.0 | – | -1.6 | – | 2.9 | – | – | – | |
| 0.0 | – | – | – | – | – | – | – | – | 0.1 | 0.0 | – | – | |
| 0.0 | – | 0.0 | – | 0.0 | – | – | – | – | – | – | – | – | |
| -2.8 | – | – | – | – | 0.0 | 0.6 | 0.0 | 0.0 | 6.8 | -6.8 | – | – | |
| 5.6 | 5.7 | 5.7 | 6.2 | 0.0 | -0.1 | 0.6 | 0.6 | 1.6 | 3.5 | 11 | 11 | 28 | |
| -5.4 | -2.8 | -2.8 | 1.8 | -4.9 | -0.3 | 0.7 | 0.7 | 0.6 | -0.7 | 6.1 | 6.1 | 12 | |
| -11 | -8.6 | -8.6 | -4.4 | -4.9 | -0.2 | 1.5 | 1.5 | -1.0 | -4.2 | -5.1 | -5.1 | -15 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.